CABA Cabaletta Bio Inc
Company Analysis
Latest News
Cabaletta Bio Pockets $128 Million From Expiring Warrants — But Can Cash Alone Cure a Stock Trading Below Its Exercise Price?
Shares of Cabaletta Bio rose 7.3% to $2.93 after the autoimmune-focused biotech disclosed it collected approximately $128.2 million in gross proceeds from...
🟢 Cabaletta Bio is trading 10.44% up today after $128.2 million in warrant exercises
Cabaletta Bio is trading at $3.02, up +10.44%, after reporting approximately $128.2 million in aggregate gross proceeds from common-stock warrant exercises...
🟢 Cabaletta Bio is trading 7.33% up today after announcing approximately $128.2 million from warrant exercises
Cabaletta Bio is trading 7.33% up now at $2.93 after announcing approximately $128.2 million in gross proceeds from common-stock warrant exercises that expired...
Cabaletta Bio Announces ~$128.2M in Gross Proceeds from Warrant Exercises
Cabaletta Bio announced the final results from the exercise of its common stock warrants, which expired on September 12, 2026. The warrants, originally issued...
Cabaletta Bio Drops to Strong Sell Rating, Signaling Significant Downside Potential
Wall Street Zen downgraded Cabaletta Bio Inc. (NASDAQ:CABA) from sell to strong sell on Saturday, September 12, 2026. The research note indicates the firm...
🟢 Cabaletta Bio is trading 5% up today amid broader risk-on sentiment
Cabaletta Bio is trading 5% up at $2.88, most likely reflecting broader risk-on market sentiment after rebounding from a 5.84% decline on September 10. -...
🔴 Cabaletta Bio is trading 5.5% down today amid hotter-than-expected wholesale inflation
Cabaletta Bio is trading 5.5% down at $2.75, pressured by a broader selloff tied to hotter-than-expected wholesale inflation. - The decline extends after...
🔴 Cabaletta Bio is trading 10.1% down today as Brent crude exceeds $100 per barrel
Cabaletta Bio is trading 10.1% down at $2.94 amid broad risk-off pressure linked to escalating U.S.-Iran tensions and Brent crude exceeding $100 per barrel. -...
🔴 Cabaletta Bio is trading 5% down today amid oil prices exceeding $100 per barrel
Cabaletta Bio is trading 5.17% down now at $3.10 amid broad risk-off trading tied to escalating U.S.-Iran tensions and oil prices exceeding $100 per barrel. -...
🔴 Cabaletta Bio is trading 5% down today amid broad risk-off and geopolitical pressure
Cabaletta Bio is trading 5.19% down now at $3.29 after a broad risk-off session marked by rising oil prices, Middle East tensions, and weaker major indexes. -...
BlackRock buys 6.6% stake in Cabaletta Bio, backing autoimmune cell therapy
BlackRock Inc. acquired a new stake in Cabaletta Bio, Inc. during the second quarter. The asset manager purchased 10,754,701 shares. A September 2, 2026, SEC...
🟢 Cabaletta Bio is trading 6.21% up today as XBI rises 2.75%
Cabaletta Bio is trading at $3.50 (+6.21%), with broader biotech strength providing the clearest near-term context. • XBI is up 2.75%, alongside the gain. •...
🟢 Cabaletta Bio is trading 5% up today
Cabaletta Bio is trading at $3.27, up 5.05% now, with no clear company-specific catalyst confirmed for September 1, 2026. - Cabaletta Bio announced upcoming...
🔴 Cabaletta Bio is trading 5.1% down in pre-market as Nasdaq Composite falls 0.53%
Cabaletta Bio is trading 5.1% down at $2.95 as broader market sentiment weakens. - Shares closed at $3.11 on August 31, 2026. - No fresh company-specific...
🔴 Cabaletta Bio falls 5.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Cabaletta Bio is trading 5% up today as Nasdaq Composite rises 1.54%
Cabaletta Bio is trading at $3.42, up 5.08%, as broader risk appetite lifts growth and biotechnology stocks. - No newly identified company-specific...
🟢 Cabaletta Bio rises 5.3% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 Cabaletta Bio is trading 10.1% up today as biotech stocks rally on positive melanoma-vaccine results
Cabaletta Bio is trading 10.1% up at $3.21, primarily as a biotech-sector rally lifts clinical-stage biotech stocks. - No new company-specific announcement...
🟢 Cabaletta Bio is trading 5% up today after sustained rese-cel Phase 1/2 responses
Cabaletta Bio is trading 5% up at $2.89 after August 17, 2026 reports highlighted encouraging rese-cel Phase 1/2 results, including sustained responses for up...
Cabaletta Bio attracts Bain Capital investment, signaling confidence in drug pipeline
Bain Capital Life Sciences Opportunities III, L.P. disclosed a 9.99% stake in Cabaletta Bio via an amended Schedule 13G filing. The firm held 7,709,188 common...